LUX LLLT Scalp Treatment

Papilla's LUX LLLT (Low-Level Laser Therapy) Scalp Treatment uses targeted photobiomodulation to energise hair follicles, reduce scalp inflammation, and support regrowth — a clinically validated, non-invasive technology for hair thinning and loss.

The LUX LLLT Scalp Treatment at Papilla Haircare applies Low-Level Laser Therapy (LLLT) — also known as photobiomodulation — directly to the scalp to stimulate biological activity within hair follicles. LLLT uses specific wavelengths of red or near-infrared light (typically 630–670 nm) to penetrate the scalp and energise mitochondria within follicular cells, increasing ATP production, improving cellular metabolism, and triggering a cascade of growth-promoting signals. Clinical evidence supports LLLT as an effective non-pharmacological treatment for androgenetic alopecia in both men and women. It works by extending the anagen (growth) phase of the hair cycle, reducing follicular inflammation, and improving microcirculation in the scalp — all of which create a more hospitable environment for hair growth. At Papilla, the LUX LLLT treatment is delivered using a professional-grade device calibrated for therapeutic dosing, distinguishing it from consumer-grade home laser caps. Sessions are non-invasive and comfortable, with no heat sensation or discomfort. There is no downtime, and patients can return to normal activities immediately. LLLT is most effective when used consistently as part of a structured programme. Papilla typically recommends sessions 1–2 times per week over an initial 12-week course, with maintenance thereafter. The treatment is commonly combined with PRP hair therapy or the Micro-Pulse Hybrid Treatment to create a synergistic multi-modal programme that addresses hair loss from multiple biological angles. Ideal candidates include those with early-to-moderate hair thinning, patients who prefer a non-injectable approach, or those using LLLT to complement other clinical treatments. It is also well-suited to patients in the maintenance phase following more intensive hair loss therapy.